EZZ Life Science Records Stellar Financial Growth

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.

EZZ Life Science Holdings Ltd. has reported a remarkable year with a 78.9% surge in revenue to $66.4 million and a 91.9% increase in net profit, reaching $6.96 million, as shown in their preliminary final report for FY24. The company launched 21 new products, expanded into new markets, including the U.S., and grew its distribution network without taking on external debt, maintaining a strong cash position. EZZ’s successful direct-to-consumer approach and omnichannel strategy significantly diversified its revenue sources and customer base, particularly in China, driving its impressive financial performance.

For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.